ZAMPIERI, MATTIA
 Distribuzione geografica
Continente #
NA - Nord America 1.552
EU - Europa 1.430
AS - Asia 474
OC - Oceania 35
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.498
Nazione #
US - Stati Uniti d'America 1.549
RU - Federazione Russa 820
IT - Italia 237
HK - Hong Kong 139
SG - Singapore 133
IE - Irlanda 126
CN - Cina 102
SE - Svezia 75
GB - Regno Unito 39
FI - Finlandia 38
AU - Australia 35
IN - India 34
JO - Giordania 31
ID - Indonesia 27
DE - Germania 22
CH - Svizzera 18
DK - Danimarca 18
NL - Olanda 7
FR - Francia 6
KR - Corea 6
BE - Belgio 5
RS - Serbia 5
PL - Polonia 4
CI - Costa d'Avorio 3
CA - Canada 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
ES - Italia 2
GR - Grecia 2
JP - Giappone 2
UA - Ucraina 2
BY - Bielorussia 1
CL - Cile 1
EU - Europa 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.498
Città #
Santa Clara 871
Dublin 124
Singapore 118
Hong Kong 109
Chandler 56
Ashburn 53
Florence 40
Moscow 38
Fairfield 37
Melbourne 35
Shanghai 31
Jakarta 27
Helsinki 26
New York 26
Seattle 25
Altamura 23
Lawrence 23
Mumbai 21
Copenhagen 18
Ann Arbor 17
Houston 17
Bern 16
West Jordan 16
Woodbridge 16
Cambridge 15
Beijing 14
Naples 14
Princeton 14
Buffalo 12
Milan 12
Munich 12
Lappeenranta 11
Prato 11
Boston 10
Los Angeles 10
Rome 10
Yubileyny 10
Kent 9
London 9
Pune 8
Medford 7
San Diego 7
Wilmington 7
Hillsboro 6
Seoul 6
Belgrade 5
Changsha 5
Inverurie 5
Lecce 5
Bologna 4
Brussels 4
Lodi 4
Warsaw 4
Abidjan 3
Boardman 3
Chennai 3
Insch 3
Kilburn 3
Leeds 3
Palermo 3
Redwood City 3
Altofonte 2
Anghiari 2
Athens 2
Bagno a Ripoli 2
Barberino Di Mugello 2
Bath 2
Bellinzago Lombardo 2
Campi Bisenzio 2
Capannori 2
Cardiff 2
Cervia 2
Cesano Boscone 2
Changzhou 2
Chiavari 2
Effeltrich 2
Falls Church 2
Fiesole 2
Frankfurt am Main 2
Genoa 2
Guayaquil 2
Gubbio 2
Livorno 2
Lurano 2
Maratea 2
Norwalk 2
Náměšť na Hané 2
Pontedera 2
Romola 2
Scarperia e San Piero 2
Toronto 2
Torremolinos 2
Trinitapoli 2
Troy 2
Tukwila 2
Turin 2
Utrecht 2
Vellore 2
Wandsworth 2
Anguillara Sabazia 1
Totale 2.134
Nome #
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 161
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 136
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 109
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 104
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 96
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 95
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 94
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 93
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 87
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 86
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 82
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 75
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 73
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 72
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 70
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 69
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 69
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 68
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 67
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 66
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery 66
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 65
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 64
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 64
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 64
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 64
Stage-specific therapy for hypertrophic cardiomyopathy 64
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 62
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 61
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis 61
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 60
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 60
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 60
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 59
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 59
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 59
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 58
Prevalence of carpal tunnel syndrome in patients with transthyretin cardiac amyloidosis 58
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 56
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 55
Standard Therapy in Cardiac Amyloidosis 55
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 54
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 54
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series 54
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study 53
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 48
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 48
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 48
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 44
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 41
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 38
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 32
Totale 3.560
Categoria #
all - tutte 15.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 5 4 5 5 0 7 0
2020/202168 4 1 1 12 5 5 3 4 12 3 15 3
2021/2022130 8 4 5 9 4 10 6 6 16 12 19 31
2022/2023543 22 75 15 16 55 81 102 34 58 18 28 39
2023/2024563 30 39 46 30 41 70 33 136 12 57 32 37
2024/20252.191 87 291 164 495 778 376 0 0 0 0 0 0
Totale 3.560